Online ISSN: 1949-2553
www.oncotarget.com
About Oncotarget
Our mission is to make scientific results rapidly and widely available. We seek to maximize the impact of research via insightful review, to enable exceptional discoveries to be shared quickly, to eliminate the border between specialties, to link different fields of biomedical science, and to foster application of basic and clinical science to fight disease.

LEARN MORE ABOUT ONCOTARGET

Does a Mechanism Linking Cellular Aging to Cellular Quiescence Exist?

Oncotarget

August 5, 2022
Researchers found that diverse geroprotectors differently affect a mechanism linking cellular aging to cellular quiescence in budding yeast. continue reading »

Oncotarget | Chemoradiation Alters PD-L1, CD8+ TILs and Mucin in Rectal Cancer

News

August 2, 2022
PRESS RELEASE: A new research paper was published in Oncotarget on July 28, 2022, entitled, “Chemoradiation-induced alteration of programmed death-ligand 1, CD8+ tumor-infiltrating lymphocytes and mucin expression in rectal cancer.” continue reading »

Oncotarget | CUDC907 promotes apoptosis of NF2 Schwannoma cells

Oncotarget

July 26, 2022
PRESS RELEASE: A new research paper was published in Oncotarget on July 19, 2022, entitled, “CUDC907, a dual phosphoinositide-3 kinase/histone deacetylase inhibitor, promotes apoptosis of NF2 Schwannoma cells.” continue reading »

Oncotarget | Predicting cancer immunotherapy response from gut microbiomes using machine learning models

News

July 19, 2022
PRESS RELEASE: A new research paper was published in Oncotarget on July 19, 2022, entitled, “Predicting cancer immunotherapy response from gut microbiomes using machine learning models.” continue reading »

How Heartburn Can Turn Into Esophageal Cancer, and a Possible Biomarker

Oncotarget

July 15, 2022
In a recent Oncotarget paper, researchers investigated telomere shortening in patients with Barrett's esophagus as a potential biomarker of high risk for esophageal cancer. continue reading »